文献速递骨显像与常规 SPECT放射性药物与辐射防护

[68Ga]Ga-Pentixafor PET/CT评估慢性骨与软组织感染:与闪烁显像的头对头比较

Evaluating chronic bone and soft tissue infections with [68Ga]Ga-Pentixafor PET/CT: a head-to-head comparison with scintigraphy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-01-27

本研究回顾性纳入20例患者共25个疑似感染灶和14个对照部位,比较[68Ga]Ga-Pentixafor PET/CT与三相骨显像及99mTc-HMPAO标记白细胞闪烁显像的诊断效能。闪烁显像灵敏度90%、特异度83%,PET/CT灵敏度100%、特异度89%,总体准确率95%对87%,差异无统计学意义(p=0.07)。

要点

  • PET/CT检出全部21个感染灶,灵敏度100%,但出现2个假阳性。
  • 闪烁显像正确识别19个感染灶,灵敏度90%、特异度83%。
  • PET/CT总体准确率95%高于闪烁显像87%,但差异未达统计学显著(p=0.07)。

核心结论

  • [68Ga]Ga-Pentixafor PET/CT检测慢性骨与软组织感染准确,提示可能作为单次扫描成像方法。
  • 结果与有限既往研究一致,需在更大队列中验证。

研究设计与样本

  • 回顾性单中心研究,纳入同时接受常规闪烁显像和[68Ga]Ga-Pentixafor PET/CT的患者。
  • 共20例患者、25个疑似感染灶和14个对照部位;无症状假体、骨科植入物及糖尿病足区域作为对照。
  • 两名核医学专家在不知患者数据情况下共识判读,视觉与定量评估。
  • 感染部位最终诊断经微生物培养和/或组织病理学确认,非感染对照部位经临床和影像随访确认。

主要发现

  • 25个疑似感染灶中21个确认感染,对照部位均无感染。
  • 闪烁显像正确识别19个感染灶,灵敏度90%、特异度83%。
  • [68Ga]Ga-Pentixafor PET/CT全部21个感染灶阳性,另有2个假阳性,灵敏度100%、特异度89%。
  • PET/CT总体准确率95%,闪烁显像87%,差异无统计学意义(p=0.07)。

关键数值与推荐

  • 闪烁显像灵敏度90%、特异度83%。
  • [68Ga]Ga-Pentixafor PET/CT灵敏度100%、特异度89%。
  • PET/CT总体准确率95%对闪烁显像87%(p=0.07)。

临床怎么用

  • 对疑似慢性骨与软组织感染,[68Ga]Ga-Pentixafor PET/CT可提供准确的单次扫描评估。
  • 需注意PET/CT存在假阳性,判读时应结合临床及其他信息。

局限性

  • 回顾性单中心设计,样本量小(20例患者、25个疑似感染灶、14个对照部位)。
  • 准确率差异未达统计学显著(p=0.07),结论需更大队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Chronic bone and soft tissue infections pose a diagnostic challenge, as conventional imaging techniques often show limited sensitivity and specificity. Given that CXCR4 chemokine receptors are expressed on lymphocytes, key mediators of chronic inflammatory response, we hypothesized that CXCR4-targeted imaging may offer enhanced diagnostic accuracy. Accordingly, this study aimed to evaluate the diagnostic performance of [68Ga]Ga-Pentixafor PET/CT in comparison with conventional 3-phase bone scintigraphy and [99mTc]Tc-HMPAO-labelled leucocyte scintigraphy in patients with suspected chronic bone and soft tissue infections. METHODS: In this retrospective single-centre study, we included patients who underwent both conventional scintigraphic imaging and [68Ga]Ga-Pentixafor PET/CT. Asymptomatic prostheses, orthopaedic implants, and diabetic foot regions within the same cohort served as controls. Two nuclear medicine specialists, blinded to patient data, evaluated imaging findings in consensus visually and quantitatively. Final diagnoses were confirmed by microbiological culture and/or histopathology for infected sites, and by clinical and radiological follow-up for non-infected control sites. RESULTS: A total of 20 patients with 25 suspected infectious foci and 14 control sites were evaluated. Of the 25 sites, 21 were confirmed to be infected; no infections were observed in the control sites. Scintigraphy correctly identified 19 infection sites (sensitivity: 90%, specificity: 83%), while [68Ga]Ga-Pentixafor PET/CT was positive in all 21 infection sites, but demonstrated two false-positives (sensitivity: 100%, specificity: 89%). PET/CT showed higher overall accuracy (95% vs. 87%), although this difference did not reach statistical significance (p = 0.07). CONCLUSION: [68Ga]Ga-Pentixafor PET/CT was accurate in detecting BSTIs, suggesting potential utility as a single-scan imaging approach. These results align with findings from limited prior studies and underscore the need for validation in larger cohorts.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Denizmen Zorba D, Has Simsek D, Sanli Y, et al. Evaluating chronic bone and soft tissue infections with [68Ga]Ga-Pentixafor PET/CT: a head-to-head comparison with scintigraphy. Eur J Nucl Med Mol Imaging. 2026. PMID: 41588208. doi:10.1007/s00259-025-07749-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。